US NewsDrugmaker Declines FDA Request to Pull Treatment After Patient DeathsSarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.SavePrintThe U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch TimesZachary StieberSenior Reporter7/21/2025|Updated: 7/22/20250:00X 1Update: Sarepta is halting all shipments of Elevidys.Original story below.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.Share this articleLeave a commentZachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected ArticlesNIH Confirms It’s Funding Research Into Ivermectin as Cancer TreatmentFeb 10, 2026FBI Releases New Images of Potential Suspect in Nancy Guthrie KidnappingFeb 10, 2026FDA Starts Reviewing Whether Common Food Preservative Is SafeFeb 10, 2026Sen. Susan Collins Launches Bid for 6th TermFeb 10, 2026